<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Haowei Z</submitter><funding>Shenzhen Science and Technology Innovation Commission</funding><funding>Science and Technology Department of Henan Province (Henan Provincial Department of Science and Technology)</funding><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><pagination>225</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12921045</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(1)</volume><pubmed_abstract>The mitochondria-localized deubiquitinase USP30 regulates mitophagy and mitochondrial homeostasis, playing a significant role in the progression of neurodegenerative diseases. However, its role in cancer remains poorly understood. Through metabolism-related gene set enrichment analysis, we identified USP30 as a key modulator of glucose metabolism in cancer cells. Utilizing quantitative proteomic and ubiquitinomic approaches coupled with co-immunoprecipitation assays, we elucidated that USP30 regulates glycolysis by interacting with hexokinase HK1 and HK2, a process dependent on its enzymatic activity. USP30 modulates the ubiquitination profile of HK1 and HK2 by preferentially removing atypical ubiquitin chains, thereby enhancing their stability, mitochondrial localization, VDAC1 binding an</pubmed_abstract><journal>Cell death &amp; disease</journal><pubmed_title>USP30-mediated Deubiquitination of Hexokinase 2 controls the metabolic fate of glucose and tumor progression.</pubmed_title><pmcid>PMC12921045</pmcid><funding_grant_id>32200438, 32301053</funding_grant_id><funding_grant_id>252102310403</funding_grant_id><funding_grant_id>JCYJ20240813142003005</funding_grant_id><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Yang H</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Xie W</pubmed_authors><pubmed_authors>Xu N</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Liao W</pubmed_authors><pubmed_authors>Haowei Z</pubmed_authors><pubmed_authors>Qin X</pubmed_authors><pubmed_authors>Zeng H</pubmed_authors></additional><is_claimable>false</is_claimable><name>USP30-mediated Deubiquitination of Hexokinase 2 controls the metabolic fate of glucose and tumor progression.</name><description>The mitochondria-localized deubiquitinase USP30 regulates mitophagy and mitochondrial homeostasis, playing a significant role in the progression of neurodegenerative diseases. However, its role in cancer remains poorly understood. Through metabolism-related gene set enrichment analysis, we identified USP30 as a key modulator of glucose metabolism in cancer cells. Utilizing quantitative proteomic and ubiquitinomic approaches coupled with co-immunoprecipitation assays, we elucidated that USP30 regulates glycolysis by interacting with hexokinase HK1 and HK2, a process dependent on its enzymatic activity. USP30 modulates the ubiquitination profile of HK1 and HK2 by preferentially removing atypical ubiquitin chains, thereby enhancing their stability, mitochondrial localization, VDAC1 binding an</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-16T12:33:35.994Z</modification><creation>2026-07-09T10:55:29.764Z</creation></dates><accession>S-EPMC12921045</accession><cross_references><pubmed>41688443</pubmed><doi>10.1038/s41419-026-08459-w</doi></cross_references></HashMap>